| 1 |
34016556 | Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy. | 2021 May 17 |
1 |
| 2 |
21437885 | Salvage radiation in men after prostate-specific antigen failure and the risk of death. | 2011 Sep 1 |
2 |
| 3 |
20553253 | Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death. | 2010 Dec |
1 |
| 4 |
19720918 | Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. | 2009 Oct 20 |
1 |
| 5 |
18258713 | Outcome of patients with hormone-refractory prostate cancer: prognostic significance of prostate-specific antigen-doubling time and nadir prostate-specific antigen. | 2008 Jan |
1 |
| 6 |
18614274 | PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging. | 2008 Nov |
1 |
| 7 |
16414494 | Active surveillance with selective delayed intervention for favorable risk prostate cancer. | 2006 Jan-Feb |
1 |
| 8 |
15681527 | Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. | 2005 Feb 1 |
2 |
| 9 |
16034457 | Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells. | 2005 Nov |
1 |
| 10 |
16170163 | Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. | 2005 Sep 20 |
1 |
| 11 |
11999465 | Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese men. | 2002 Jan |
2 |
| 12 |
12454114 | Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. | 2002 Dec 1 |
3 |
| 13 |
9626230 | Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis. | 1998 Jun |
1 |